April 7, 2022

African ancestry, high BMI predictive of worse breast cancer outcomes

March 25, 2022

Enrollment in TMIST breast cancer screening trial surpasses halfway mark; Black participation rises above 20%

March 17, 2022

NCI-MATCH umbrella trial adds arm for LAG-3 expressing, mismatch repair deficient cancers

March 15, 2022

The results of the EA8141 phase II trial are part of mounting evidence showing the benefits of neoadjuvant chemotherapy

March 8, 2022

JAMA Oncology publishes TAILORx data showing racial and neighborhood disparities in breast cancer

March 1, 2022

FDA notes the NCI-MATCH trial in its release of new guidance on master protocols and expansion cohorts

February 28, 2022

Dr. Edith Mitchell discusses ECOG-ACRIN’s work to improve representation of minority populations in cancer clinical trials

February 28, 2022

E1912 and other trials spur emergence of small molecule-inhibitor therapies for chronic lymphocytic leukemia

November 16, 2021

Press Release: Practice-changing trial results for advanced skin cancer

ECOG-ACRIN Cancer Research Group